Introduction
There are 2 common analytical methods of determining plasma or serum total protein concentrations: biuret spectrophotometric assays and refractometry. A recent case report described a pseudohypoproteinemia in markedly icteric serum when the serum was assayed with a biuret total protein assay. 1 However, the bilirubin concentration at which the interference becomes detectable was not established. In the case report, the refractometric total protein concentration did not appear to be adversely affected by the hyperbilirubinemia. A recent report established that serum bilirubin concentrations as high as 41 mg/dL do not affect the estimation of total protein concentrations by refractometry. 2 The biuret method is the most common spectrophotometric method of measuring serum total protein concentration. The biuret reaction depends on the number of peptide bonds in the sample; thus, the protein concentration in the sample. In the reaction, proteins form complexes with copper in alkaline solutions and create a blue-purple product; the amount of product is measured with spectrophotometry. The method is named biuret method because a similar copper reaction occurs with the organic compound biuret, a condensation product of 2 urea molecules.
Some package inserts state that bilirubin can interfere with the biuret assay, but the magnitude of interference or reason for the interference is not typically stated. This study evaluated the effect of adding increasing amounts of bilirubin on a biuret serum total protein assay.
Materials and methods

Blood collection
For each set of samples, venous blood was collected from a healthy, fasted Greyhound dog with syringes and then transferred to evacuated tubes. After approximately 30 min, tubes were centrifuged and nonlipemic and nonhemolyzed sera were harvested.
Bilirubin stock solution and preparing icteric sera
A bilirubin stock solution of 400 mg/dL was prepared by dissolving 40 mg of bilirubin powder (Sigma-Aldrich, St. Louis, MO) in 10 mL of 0.1 M sodium hydroxide (NaOH). 5, 6 Serial dilutions of the bilirubin stock solution with 0.1 M NaOH were mixed with constant proportions of sera (1 part bilirubin solution + 9 parts serum) to create bilirubin concentrations between 1 and 40 mg/dL (17 and 684 mol/L) in the first set of spiked sera, and between 4 and 35 mg/dL (68 and 598 mol/L) in the second set of spiked sera. The first set of spiked sera was assayed to document the interference; the second set was assayed to confirm findings of the first set, and to explore the reason for the interference. Control sera were prepared by mixing with 0.1 M NaOH solution in comparable proportions. Based on a previous study using the same preparation methods, nearly all bilirubin in the spiked sera was unconjugated.
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Assays for serum total protein, total bilirubin, and direct bilirubin concentrations
Clinical chemistry assays were completed on the day of blood collection using an automated chemistry analyzer (Cobas 6000 with Cobas c501 module, Roche Diagnostics, Indianapolis, IN, USA) and the manufacturer's reagents. The analyzer used a reaction monitoring system in which absorbance readings were recorded while the reaction cuvette, located on a rotating reaction disc, passed across the optical path of the instrument's photometer.
Each analytical assay had specific timed readings for the calculation of an analyte's concentration.
The total bilirubin assay was a modified Malloy-Evelyn method. 7 Samples with bilirubin concentrations > 35 mg/dL were automatically diluted. Indices for lipemia, hemolysis and icterus were calculated by the chemistry analyzer by using absorbance differences at 3 bichromatic wavelength pairs (700/660 for lipemia, 600/570 for hemolysis, and 505/480 for icterus), and the icterus index was reported as a number that approximates the total bilirubin concentration (in mg/dL).
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The analyzer's biuret total protein assay was a 2-point-end, bichromatic assay ( Figure 1 ), 9 it will be referred to as the bichromatic biuret assay from this point forward; the formulae used to calculate the total protein concentration in a sample are provided ( Figure 2 ). 9 During the previous 5 months and including the weeks of this study, the coefficient of variation (CV) for the bichromatic biuret assay were 1.5 % for commercial level-1 human control serum (mean concentration of 6.0 g/dL, standard deviation 0.1 g/dL) and 1.5 % for commercial level-2 human control serum (mean concentration of 4.4 g/dL, standard deviation of 0.1 g/dL). Based on the assay's analytical precision, any change to biuret total protein concentration in the spiked samples that was > 0.2 g/dL was considered a true change/interference and not a random analytic error.
A refractometer (Leica TS Meter Refractometer Model 10400B) with a total solids percent scale (g/100g) was used to determine refractometric total protein concentrations. The total solids percentage of a sample was converted to a total protein concentration (g/dL) using Wolf's conversion table. 910 This method of obtaining a refractometric total protein concentration was selected because it provided the best agreement with the bichromatic biuret assay among 3 available refractometers. 2 The refractometer was calibrated with deionized water to 1.000 on the urine specific gravity scale prior to sample analysis. To monitor analytical precision the day of analyzing the first set of sera, the prespiked serum was analyzed 8 times by refractometry and the bichromatic biuret assay.
The first set of spiked sera was analyzed by refractometry and the bichromatic biuret assay in duplicates, and the mean concentration of each sample was recorded for comparisons.
The second set of prespiked and spiked sera was assayed 5 times, and the mean concentration of each sample was recorded for comparisons. In both sets of samples, the biuret total protein concentrations were evaluated to detect negative interference. Actual absorbance data of the second set of spiked sera were evaluated to determine the reason for the negative interference.
Results
The mean total protein concentration in the first prespiked serum by both methods (refractometry and biuret reaction) was 5.8 g/dL (CV 0.9 % and 1.4 %, respectively).
In the first set of spiked sera, lower bichromatic biuret total protein concentrations (> 0. 
Discussion
Increasing serum bilirubin concentrations in both sets of spiked sera resulted in a negative interference of the measurement of the total protein concentration by the bichromatic biuret method while the refractometric total protein concentrations remained the same in the first set of spiked samples.
The maximum spectral absorption of bilirubin in serum is near 455 nm, 1011 therefore, the interfering agent found in the secondary-wavelength (700 nm) absorbance was likely not bilirubin. However, bilirubin can be degraded to biliverdin in an alkaline environment. 1112 Because the biuret reaction occurred in an alkaline solution, we hypothesize that some of the bilirubin converted to biliverdin, which has maximum spectral absorbance near 700 nm, 12, 1313, 14 the secondary wavelength of the evaluated biuret assay. Assays to measure biliverdin concentrations were not attempted and thus this hypothesis was not tested or confirmed.
Nevertheless it can be assumed that the degree of interference due to biliverdin or another compound derived from bilirubin will be roughly proportional to the initial amount of bilirubin present in the reaction cuvette. Until the identity and property of such compounds are clarified, it will be difficult to predict to what degree hyperbilirubinemia will interfere with bichromatic biuret assay.
The presence of a decreased total protein concentration in the presence of marked hyperbilirubinemia could lead to erroneous conclusions if the pseudohypoproteinemia is not recognized.. This study documents that marked hyperbilirubinemia can be associated with a false decrease in the serum total protein concentration measured by a bichromatic biuret assay. The interferent is not bilirubin but is related to the presence of bilirubin in the serum. The negative interference was found in one bichromatic, 2-point-end assay; it is not known if a similar interference will be found with other biuret assays. Calculation of total protein concentrations in "NaOH only" sample and "S8" serum samples in the second set of sera (see Table 1 for sources of absorbance values) Figure 2 ) that is used to calculate a sample's total protein concentration || 1A is the primary absorbance for the biuret assay at 546 nm which represents total absorbance by the reaction cuvette. ** 2A is the secondary absorbance for the biuret assay at 700 nm which represents absorbance due to interfering substances.
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